Skip to main content
Top
Published in: Drugs & Aging 12/2009

01-12-2009 | Original Research Article

Epidemiology of Suboptimal Prescribing in Older, Community Dwellers

A Two-Wave, Population-Based Survey in Dicomano, Italy

Authors: Dr. Francesco Lapi, Claudia Pozzi, Giampiero Mazzaglia, Andrea Ungar, Stefano Fumagalli, Niccolò Marchionni, Pierangelo Geppetti, Alessandro Mugelli, Mauro Di Bari

Published in: Drugs & Aging | Issue 12/2009

Login to get access

Abstract

Background

Because of co-morbidity, older persons are often exposed to use of an excessive number of drugs, which per se implies also use of inappropriate drugs or of potentially interacting drugs (‘suboptimal prescribing’). Time trends of suboptimal prescribing in older, community dwellers have been poorly investigated, particularly in Italy.

Objective

To evaluate the time-course modification of suboptimal prescribing in older, community dwellers.

Methods

We conducted a study on an Italian cohort of older (aged ≥65 years), community dwellers for whom data were collected in a two-wave (1995 and 1999), population-based survey. Suboptimal prescribing was defined as occurrence of polypharmacy (≥5 medications), prescription of inappropriate medications (according to 1991 Beers’ criteria) and prescription of potentially interacting drugs (as identified by the Micromedex® Drug-Reax® system). All outcome variables were modelled as continuous and dichotomous.

Results

In 568 participants (59.9% women, mean±standard error age 72.7±0.2 years), polypharmacy and potentially interacting drugs were more prevalent in 1999 than in 1995, while prevalence of inappropriate drugs was lower in 1999. The proportion of participants receiving polypharmacy was nearly 3-fold greater in 1999 than in 1995 (21.6% vs 8.8%; p<0.001). After adjustment for disability, coronary artery disease/stroke, heart failure and other co-morbidities, polypharmacy was twice as prevalent in 1999 as in 1995, with a mean increase of 0.5 drugs per participant. In contrast, in models adjusted for the same variables and also for polypharmacy, inappropriate prescribing was reduced (60% lower prevalence, 0.06 mean reduction in prescriptions per participant) in 1999 compared with 1995. In multivariable models, no change was observed in the number of potentially interacting prescriptions.

Conclusions

Between 1995 and 1999, the number of prescriptions received by a cohort of older, community dwellers increased substantially, even after controlling for co-morbidity. On the other hand, when controlling for polypharmacy, other indicators of suboptimal prescribing remained unaffected or even decreased, suggesting that even increasing levels of polypharmacy do not necessarily imply other forms of suboptimal prescribing among older persons.
Literature
1.
go back to reference ISTAT. L’uso dei farmaci in Italia. Rapporto nazionale anno 2004. Roma: Il Pensiero Scientifico Editore, 2005 ISTAT. L’uso dei farmaci in Italia. Rapporto nazionale anno 2004. Roma: Il Pensiero Scientifico Editore, 2005
2.
go back to reference Anderson G, Kerluke K. Distribution of prescription drug exposures in the elderly: description and implications. J Clin Epidemiol 1996; 49(8): 929–35PubMedCrossRef Anderson G, Kerluke K. Distribution of prescription drug exposures in the elderly: description and implications. J Clin Epidemiol 1996; 49(8): 929–35PubMedCrossRef
3.
go back to reference Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. CMAJ 1994; 150(11): 1801–9PubMed Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. CMAJ 1994; 150(11): 1801–9PubMed
4.
go back to reference Hanlon JT, Lindblad CI, Hajjar ER, et al. Update on drug-related problems in the elderly. Am J Geriatr Pharmacother 2003; 1(1): 38–43PubMedCrossRef Hanlon JT, Lindblad CI, Hajjar ER, et al. Update on drug-related problems in the elderly. Am J Geriatr Pharmacother 2003; 1(1): 38–43PubMedCrossRef
5.
go back to reference McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56(2): 163–84PubMedCrossRef McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56(2): 163–84PubMedCrossRef
6.
go back to reference Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57(1): 6–14PubMedCrossRef Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57(1): 6–14PubMedCrossRef
7.
go back to reference Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157(14): 1531–6PubMedCrossRef Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157(14): 1531–6PubMedCrossRef
8.
go back to reference Beers MH, Fink A, Beck JC. Screening recommendations for the elderly. Am J Public Health 1991; 81(9): 1131–40PubMedCrossRef Beers MH, Fink A, Beck JC. Screening recommendations for the elderly. Am J Public Health 1991; 81(9): 1131–40PubMedCrossRef
9.
go back to reference Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151(9): 1825–32PubMedCrossRef Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151(9): 1825–32PubMedCrossRef
10.
go back to reference De Wilde S, Carey IM, Harris T, et al. Trends in potentially inappropriate prescribing amongst older UK primary care patients. Pharmacoepidemiol Drug Saf 2007; 16(6): 658–67PubMedCrossRef De Wilde S, Carey IM, Harris T, et al. Trends in potentially inappropriate prescribing amongst older UK primary care patients. Pharmacoepidemiol Drug Saf 2007; 16(6): 658–67PubMedCrossRef
11.
go back to reference Maio V, Yuen EJ, Novielli K, et al. Potentially inappropriate medication prescribing for elderly outpatients in Emilia Romagna, Italy: a population-based cohort study. Drugs Aging 2006; 23(11): 915–24PubMedCrossRef Maio V, Yuen EJ, Novielli K, et al. Potentially inappropriate medication prescribing for elderly outpatients in Emilia Romagna, Italy: a population-based cohort study. Drugs Aging 2006; 23(11): 915–24PubMedCrossRef
12.
go back to reference Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293(11): 1348–58PubMedCrossRef Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293(11): 1348–58PubMedCrossRef
13.
go back to reference Landi F, Russo A, Liperoti R, et al. Impact of inappropriate drug use on physical performance among a frail elderly population living in the community. Eur J Clin Pharmacol 2007; 63(8): 791–9PubMedCrossRef Landi F, Russo A, Liperoti R, et al. Impact of inappropriate drug use on physical performance among a frail elderly population living in the community. Eur J Clin Pharmacol 2007; 63(8): 791–9PubMedCrossRef
14.
go back to reference Onder G, Landi F, Liperoti R, et al. Impact of inappropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005; 61(5–6): 453–9PubMedCrossRef Onder G, Landi F, Liperoti R, et al. Impact of inappropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005; 61(5–6): 453–9PubMedCrossRef
15.
go back to reference Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49(2): 200–9PubMedCrossRef Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49(2): 200–9PubMedCrossRef
16.
go back to reference Di Bari M, Marchionni N, Ferrucci L, et al. Heart failure in community-dwelling older persons: aims, design and adherence rate of the ICARe Dicomano project: an epidemiologic study. Insufficienza Cardiaca negli Anziani Residenti a Dicomano. J Am Geriatr Soc 1999; 47(6): 664–71PubMed Di Bari M, Marchionni N, Ferrucci L, et al. Heart failure in community-dwelling older persons: aims, design and adherence rate of the ICARe Dicomano project: an epidemiologic study. Insufficienza Cardiaca negli Anziani Residenti a Dicomano. J Am Geriatr Soc 1999; 47(6): 664–71PubMed
17.
go back to reference Bjerrum L, Rosholm JU, Hallas J, et al. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol 1997; 53(1): 7–11PubMedCrossRef Bjerrum L, Rosholm JU, Hallas J, et al. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol 1997; 53(1): 7–11PubMedCrossRef
18.
go back to reference Espino DV, Bazaldua OV, Palmer RF, et al. Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study. J Gerontol A Biol Sci Med Sci 2006; 61(2): 170–5PubMedCrossRef Espino DV, Bazaldua OV, Palmer RF, et al. Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study. J Gerontol A Biol Sci Med Sci 2006; 61(2): 170–5PubMedCrossRef
19.
go back to reference Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63(2): 187–95PubMedCrossRef Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63(2): 187–95PubMedCrossRef
20.
go back to reference Micromedex®: Thomson DRUG-REAX® system [internet database]. Greenwood Village (CO): Thomson Reuters (Healthcare) Inc. [online]. Available from URL: http://www.thomsonhc.com [Accessed 2008 Feb] Micromedex®: Thomson DRUG-REAX® system [internet database]. Greenwood Village (CO): Thomson Reuters (Healthcare) Inc. [online]. Available from URL: http://​www.​thomsonhc.​com [Accessed 2008 Feb]
21.
go back to reference Di Bari M, Virgillo A, Matteuzzi D, et al. Predictive validity of measures of comorbidity in older community dwellers: the Insufficienza Cardiaca negli Anziani Residenti a Dicomano Study. J Am Geriatr Soc 2006; 54(2): 210–6PubMedCrossRef Di Bari M, Virgillo A, Matteuzzi D, et al. Predictive validity of measures of comorbidity in older community dwellers: the Insufficienza Cardiaca negli Anziani Residenti a Dicomano Study. J Am Geriatr Soc 2006; 54(2): 210–6PubMedCrossRef
22.
go back to reference Vines SK, Farrington CP. Within-subject exposure dependency in case-crossover studies. Stat Med 2001; 20(20): 3039–49PubMedCrossRef Vines SK, Farrington CP. Within-subject exposure dependency in case-crossover studies. Stat Med 2001; 20(20): 3039–49PubMedCrossRef
23.
go back to reference Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50(12): 1962–8PubMedCrossRef Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50(12): 1962–8PubMedCrossRef
24.
go back to reference Stuart B, Kamal-Bahl S, Briesacher B, et al. Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999. Am J Geriatr Pharmacother 2003; 1(2): 61–74PubMedCrossRef Stuart B, Kamal-Bahl S, Briesacher B, et al. Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999. Am J Geriatr Pharmacother 2003; 1(2): 61–74PubMedCrossRef
25.
go back to reference Gagne JJ, Maio V, Rabinowitz C. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 2008; 33(2): 141–51PubMedCrossRef Gagne JJ, Maio V, Rabinowitz C. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 2008; 33(2): 141–51PubMedCrossRef
26.
go back to reference Nobili A, Pasina L, Tettamanti M, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther 2009; 34(4): 377–86PubMedCrossRef Nobili A, Pasina L, Tettamanti M, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther 2009; 34(4): 377–86PubMedCrossRef
27.
go back to reference Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294(6): 716–24PubMedCrossRef Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294(6): 716–24PubMedCrossRef
28.
29.
go back to reference Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 2003; 48(2): 133–43PubMedCrossRef Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 2003; 48(2): 133–43PubMedCrossRef
30.
go back to reference Kuijpers MA, van Marum RJ, Egberts AC, et al. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008 Jan; 65(1): 130–3PubMedCrossRef Kuijpers MA, van Marum RJ, Egberts AC, et al. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008 Jan; 65(1): 130–3PubMedCrossRef
31.
go back to reference Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982; 116(1): 114–22PubMed Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982; 116(1): 114–22PubMed
32.
go back to reference Martin LM, Leff M, Calonge N, et al. Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 2000; 18(3): 215–8PubMedCrossRef Martin LM, Leff M, Calonge N, et al. Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 2000; 18(3): 215–8PubMedCrossRef
Metadata
Title
Epidemiology of Suboptimal Prescribing in Older, Community Dwellers
A Two-Wave, Population-Based Survey in Dicomano, Italy
Authors
Dr. Francesco Lapi
Claudia Pozzi
Giampiero Mazzaglia
Andrea Ungar
Stefano Fumagalli
Niccolò Marchionni
Pierangelo Geppetti
Alessandro Mugelli
Mauro Di Bari
Publication date
01-12-2009
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 12/2009
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/11319390-000000000-00000

Other articles of this Issue 12/2009

Drugs & Aging 12/2009 Go to the issue

Acknowledgments

Acknowledgement

Adis Drug Evaluation

Bimatoprost

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.